Schedule 13D ownership disclosure

Whitehawk Therapeutics, Inc.

Common Stock · CUSIP: 00032Q104

Event date: 2024-12-19

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • ACUTA CAPITAL PARTNERS, LLCReported CIK 0001582844

    Shares: 1,849,402.00 · Class: 7.5%

  • Anupam DalalReported CIK 0001602474

    Shares: 1,921,297.00 · Class: 7.8%

  • Acuta Capital Fund, LPReported CIK 0001601391

    Shares: 1,572,698.00 · Class: 6.4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000935836-25-000082
Form type
SCHEDULE 13D/A
Filer
ACUTA CAPITAL PARTNERS, LLC
CIK
CIK 1582844
Filed
Jan 24, 2025
Reporting period
Dec 19, 2024
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub